ONDANSETRON INJECTION USP
Google image searchProduct monograph
Active ingredient
ondansetron (ondansetron hydrochloride dihydrate), 2 MG/ML
DIN: 02462257
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: MULTIDOSE VIAL
Schedule: Prescription
Company: STERIMAX INC
Date: 28-APR-2021
ATC:
- A04 — ANTIEMETICS AND ANTINAUSEANTS (ATC, ATC/DDD, )
- A04A — ANTIEMETICS AND ANTINAUSEANTS (ATC, ATC/DDD)
- A04AA — Serotonin (5HT3) antagonists (ATC, ATC/DDD)
- A04AA01 — ONDANSETRON (ATC/DDD)
Reference brand drug: Zofran
Pharmaceutical standard: USP
